On the other hand, patients with the HGSC tumor subtype had significantly less frequently mutated KRAS and TP53 (p < .001 and p = .002, respectively; Table 3), and they had significantly higher KRAS transcript levels (p = .004, Figure 1E) compared to those with other EOC subtypes. This evidence concerns the gene KRAS and neoplasm.